CDK6 and breast carcinoma: Moreover, miR-1299 inhibits cell cycle progression by binding to the transcript of one of its targets, CDK6. These results indicate that miR-1299 can act as a tumor suppressor in breast cancer cells and regulate the growth and metastasis of breast cancer through the hsa_circ_0136666/miR-1299/CDK6 axis.